The mechanism of the susceptibility to infection in diabetes and the new management

糖尿病感染易感机制及新管理

基本信息

项目摘要

In poorly controlled diabetic patients and streptozotocin-induced diabetic rats, neutrophil bactericidal function (oxygen-derived free radicals generation) was clearly decreased. Especially, the generation of superoxide anion and the myeloperoxidase (MPO) dependent radicals were reduced compaired to control. The MPO activity was also decreased in neutrophils from poorly controlled diabetic patients, which was correlated to the increase in HbA1c.Two drugs, granulocyte-colony stimulating facto (G-CSF) and epairestat, an aldose reductase inhibitor, were improved the diabetic-induced decrease in the generation of oxygen-derived free radicals by poorly controlled diabetic patients and diabetic rats. This improvement by G-CSF was more significant in patients with more poorly blood glucose control. In diabetic rats, cytosolic sorbitol concentration was increased. Epalrestat not only suppressed this increase in sorbitol concentration but increased the impaired neutrophil bactericidal function. There was a negative correlation between epairestat-induced decrease in sorbitol concentration and epairestat-induced increase in neutrophil bactericidal function.It is well known that the susceptibility to infection is dependent on the impaired neutrophils bactericidal function. This study suggested that the susceptibility to infection in diabetes may be due to the impairment of the generation of oxygen-derived free radicals by neutrophils. Some drugs (e.g. (G-CSF and epairestat) may be useful as drug to prevent the susceptibility to infection in diabetes.
在控制不良的糖尿病患者和链脲佐菌素诱导的糖尿病大鼠中,中性粒细胞的杀菌功能(氧源自由基的产生)明显下降。特别是,与对照组相比,超氧阴离子和髓过氧化物酶(MPO)依赖自由基的产生减少。控制不良的糖尿病患者的中性粒细胞MPO活性也降低,这与HbA1c升高有关。两种药物,粒细胞集落刺激因子(G-CSF)和醛糖还原酶抑制剂依帕司他(epairestat),可以改善糖尿病患者和糖尿病大鼠在糖尿病诱导的氧源性自由基生成的减少。G-CSF的这种改善在血糖控制较差的患者中更为显著。糖尿病大鼠细胞内山梨醇浓度升高。依帕司他不仅抑制山梨醇浓度的增加,而且增加了受损的中性粒细胞杀菌功能。epairestat诱导的山梨醇浓度下降与epairestat诱导的中性粒细胞杀菌功能增加呈负相关。众所周知,对感染的易感性依赖于中性粒细胞杀菌功能的受损。本研究提示糖尿病患者对感染的易感性可能是由于中性粒细胞产生氧源自由基的功能受损。一些药物(如G-CSF和伊替司他)可作为预防糖尿病易感性感染的药物。

项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
佐藤則之、 森 昌朋: "ミエロペルオキシダーゼ" 日本臨床. 56. 246-250 (1998)
Noriyuki Sato、Masatomo Mori:“髓过氧化物酶”日本临床杂志 56. 246-250 (1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sato,N., Kashima,K., Tanaka,Y., Shimizu,H., Mori,M.: "Effect of Granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients" Diabetes. 46. 133-137 (1
Sato,N.、Kashima,K.、Tanaka,Y.、Shimizu,H.、Mori,M.:“粒细胞集落刺激因子对 NIDDM 控制不良的中性粒细胞中氧自由基生成和髓过氧化物酶活性的影响
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
佐藤 則之.清水 弘行.森 昌朋: "ミエロペルオキシダーゼ" 日本臨床(増刊号)糖尿病3. 728号. 246-250 (1998)
Noriyuki Sato。Hiroyuki Shimizu。Masayuki Mori:“髓过氧化物酶”日本临床(特刊)糖尿病 3. No. 728. 246-250 (1998)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
佐藤 則之, 森 昌朋: "甲状腺刺激ホルモン(TSH)" 臨床スポーツ医学(臨時増刊号)スポーツと臨床検査. 14巻. 115-117 (1997)
Noriyuki Sato,Masatomo Mori:“促甲状腺激素(TSH)”临床运动医学(特刊)运动和临床测试第 14 卷。115-117(1997 年)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
上原豊、 佐藤則之、 森昌朋: "顆粒球エラスターゼ" 日本臨床. 56. 241-245 (1998)
Yutaka Uehara、Noriyuki Sato 和 Masatomo Mori:“粒细胞弹性蛋白酶”日本临床杂志 56. 241-245 (1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SATO Noriyuki其他文献

EFFICIENT ESTIMATION METHOD FOR FUTURE CHANGES IN DESIGN WAVE HEIGHT USING d4PDF
使用 d4PDF 设计波高未来变化的有效估计方法
面的方向集中砕波下の渦及び流れ構造
表面定向集中破碎波下的涡流和流动结构
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    NOMURA Akihiro;SATO Noriyuki;ISHIKAWA Hiroki;HAYAKAWA Tetsuya;IWASAKI Shinsuke;OTSUKA Junichi;MORI Nobuhito;WATANABE Yasunori;藤澤蓮
  • 通讯作者:
    藤澤蓮

SATO Noriyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SATO Noriyuki', 18)}}的其他基金

Extracellular Hsp90 plays a pivotal role in innate immunity and adaptive immunity
细胞外Hsp90在先天免疫和适应性免疫中发挥着关键作用
  • 批准号:
    24659165
  • 财政年份:
    2012
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
A study on the economic structure of Mongolia in the Qing era from the viewpoint of the Chinese commercial district "Mai-mai-cheng"
从中国商圈“买买城”看清代蒙古经济结构
  • 批准号:
    23720341
  • 财政年份:
    2011
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
patho-physiologic role of HSP90 in the aseptic inflammatory process
HSP90 在无菌炎症过程中的病理生理作用
  • 批准号:
    22659075
  • 财政年份:
    2010
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Molecular immunopathology of human cancer stem cell
人类癌症干细胞的分子免疫病理学
  • 批准号:
    21249025
  • 财政年份:
    2009
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of therapeutic cancer vaccine
治疗性癌症疫苗的开发
  • 批准号:
    17016061
  • 财政年份:
    2005
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Immune response and escape in human cancers
人类癌症的免疫反应和逃逸
  • 批准号:
    16209013
  • 财政年份:
    2004
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Human cancer vaccines
人类癌症疫苗
  • 批准号:
    12213116
  • 财政年份:
    2000
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Identification of human tumor antigens and immunotherapy
人类肿瘤抗原的鉴定和免疫治疗
  • 批准号:
    11694301
  • 财政年份:
    1999
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
HLA-A31-restricted gastric tumor antigenic peptide and clinical application
HLA-A31限制性胃肿瘤抗原肽及其临床应用
  • 批准号:
    09557019
  • 财政年份:
    1997
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
T Cell Response with Stress Proteins
T 细胞对应激蛋白的反应
  • 批准号:
    09470067
  • 财政年份:
    1997
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

CAREER: Impact of MRI contrast agent design on nanoscale interactions with neutrophils and platelets
职业:MRI 造影剂设计对中性粒细胞和血小板纳米级相互作用的影响
  • 批准号:
    2339015
  • 财政年份:
    2024
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Standard Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
  • 批准号:
    MR/Y003365/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Research Grant
Basic research for the development of novel therapy targeting neutrophils and organ fibrosis to regulate chronic inflammation
开发针对中性粒细胞和器官纤维化以调节慢性炎症的新疗法的基础研究
  • 批准号:
    23K06501
  • 财政年份:
    2023
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Role of Neutrophils in Ischemia/Reperfusion Injury following Acute Stroke
中性粒细胞在急性中风后缺血/再灌注损伤中的作用
  • 批准号:
    10606952
  • 财政年份:
    2023
  • 资助金额:
    $ 0.32万
  • 项目类别:
Platelet-derived microvesicles modulate the bioenergetic state of neutrophils in rheumatoid arthritis
血小板衍生的微泡调节类风湿性关节炎中性粒细胞的生物能状态
  • 批准号:
    493872
  • 财政年份:
    2023
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Operating Grants
Elucidating how inflammation modulates metabolic signals in tumoricidal neutrophils in breast cancer.
阐明炎症如何调节乳腺癌中杀瘤中性粒细胞的代谢信号。
  • 批准号:
    495143
  • 财政年份:
    2023
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Miscellaneous Programs
Metabolic mechanisms of pro-resolutive neutrophils in chronic inflammatory diseases
慢性炎症性疾病中促消退性中性粒细胞的代谢机制
  • 批准号:
    488493
  • 财政年份:
    2023
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Operating Grants
Immunosuppression and Metabolic Rewiring in Tumor-infiltrating Neutrophils
肿瘤浸润中性粒细胞的免疫抑制和代谢重组
  • 批准号:
    10637160
  • 财政年份:
    2023
  • 资助金额:
    $ 0.32万
  • 项目类别:
Clinical application of cancer immunity-induced neutrophils and immunosuppressive neutrophils
癌症免疫诱导的中性粒细胞和免疫抑制性中性粒细胞的临床应用
  • 批准号:
    23K08751
  • 财政年份:
    2023
  • 资助金额:
    $ 0.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Harnessing neutrophils to improve the efficacy of immune checkpoint inhibitors in breast cancer
利用中性粒细胞提高免疫检查点抑制剂在乳腺癌中的疗效
  • 批准号:
    10644508
  • 财政年份:
    2023
  • 资助金额:
    $ 0.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了